Filing Details
- Accession Number:
- 0001140361-18-028996
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-18 17:00:48
- Reporting Period:
- 2018-06-14
- Accepted Time:
- 2018-06-18 17:00:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1581720 | Loxo Oncology Inc. | LOXO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1536368 | Anne Lori Kunkel | C/O Loxo Oncology, Inc. 281 Tresser Blvd, 9Th Floor Stamford CT 06901 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-06-14 | 27,343 | $3.65 | 34,183 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-06-14 | 3,096 | $20.91 | 37,279 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-06-14 | 1,953 | $24.18 | 39,232 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-06-14 | 28,440 | $180.28 | 10,792 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-06-14 | 2,411 | $181.48 | 8,381 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-06-14 | 1,541 | $182.35 | 6,840 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-06-15 | 1,235 | $175.64 | 5,605 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-06-15 | 5,601 | $177.12 | 4 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-06-15 | 4 | $177.79 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Director Stock Option (right to buy) | Disposition | 2018-06-14 | 27,343 | $0.00 | 27,343 | $3.65 |
| Common Stock | Director Stock Option (right to buy) | Disposition | 2018-06-14 | 3,096 | $0.00 | 3,096 | $20.91 |
| Common Stock | Director Stock Option (right to buy) | Disposition | 2018-06-14 | 1,953 | $0.00 | 1,953 | $24.18 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 27,344 | 2024-06-18 | No | 4 | M | Direct | |
| 4,716 | 2025-07-27 | No | 4 | M | Direct | |
| 5,859 | 2026-06-09 | No | 4 | M | Direct |
Footnotes
- Represents the aggregate of sales effected on the same day at different prices
- Represents the weighted average sales price per share. The shares sold at prices ranging from $180.00 to $180.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $181.01 to $181.92 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $182.31 to $182.83 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on June 20, 2017.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $175.36 to $176.10 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $176.68 to $177.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- The stock option is fully vested and is immediately exercisable.
- The stock option vests and becomes exercisable in 12 equal monthly installments beginning one month after the grant date, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
Billionaire Hedge Funds
